Pulling SEC filings + quote and writing the call…

HORACE MANN EDUCATORS CORP /DE/
Next earnings Aug 4, 2026 · consensus $0.70 EPS, $448M rev
Last earnings -0.7% on 2026-05-06
Cheap, recovering educator-focused insurer: 13.3x earnings, 1.4x book, EPS +57% and operating cash flow surging.
Diluted EPS $3.90 · FY2025
Quality fundamentals and an attractive price line up (~175% below fair value) — the rarer case where both the business and the entry look good.
Horace Mann is a multiline insurer to the education niche that has clearly turned the corner after a rough patch. Net income has climbed from a $19.8M trough in FY2022 to $45M (2023), $103M (2024) and $162M in FY2025 (+57.7%), with diluted EPS up 57.3% to $3.90. Revenue has compounded steadily ($1.33B→$1.70B since 2021), but the real story is normalization of profitability — net margin recovered to 9.5% and ROE to 10.9%. Operating cash flow of $553M (+22.4%) is roughly 3.4x net income, underscoring that earnings are cash-backed and that the insurance subsidiaries throw off cash 'generally well in excess' of policy obligations per the MD&A.
The MD&A explains the earnings inflection: management states that 'because of the annuity reinsurance transaction, the spread in our retained annuity business is achieving our targeted returns.' Removing the drag from the legacy annuity spread is precisely what should make the post-2022 recovery durable rather than a one-off. Capital management is disciplined — equity grew 15.2% to $1.48B, dividends paid rose to $57.1M (~2.7% yield), and the September 2025 refinancing replaced $250M of 4.50% notes with $300M of 4.70% notes due 2030, clearing near-term maturity risk (current portion of debt is $0). Long-term debt of $593M against $1.48B equity is modest for an insurer; the 9.3x liabilities/equity ratio is mostly policyholder reserves, not leverage.
Is HMN a buy? The one-page verdict, explained →
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.33B | $1.38B | $1.49B | $1.60B | $1.70B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $170M | $19.8M | $45.0M | $103M | $162M |
| Diluted EPS | $4.04 | $0.47 | $1.09 | $2.48 | $3.90 |
| Net margin | 12.8% | 1.4% | 3.0% | 6.4% | 9.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting voting results filed; routine director/proposal outcomes, no financial impact
Q1 2026 (period 3/31): continued momentum off record FY2025 results
Q1 2026 earnings release issued amid record FY2025 earnings momentum
2026 proxy: board, exec comp and AGM proposals; governance routine
Officer/director change disclosed; leadership transition, no immediate financial effect
FY2025: revenue $1.70B (+7%), net income $162M (+58%), equity +15%, OCF $553M
Q4/FY2025 earnings: net income +58% to $162M, EPS $3.90
Q3 2025: profit recovery continuing as P&C margins and investment income improve
Q3 2025 earnings release; on track for record full-year profit
Sources: SEC EDGAR (CIK 0000850141, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/30/2026, 4:33:46 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 12:33 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 2 sales
| 2026-07-01 | ZURAITIS MARITA President & CEO | Sell | 7.50K @ $52.62 | $395K |
| 2026-06-24 | ZURAITIS MARITA President & CEO | Exercise | 70.4K @ $41.95 | $2.95M |
| 2026-06-24 | ZURAITIS MARITA President & CEO | Tax | 63.7K @ $50.75 | $3.23M |
| 2026-06-24 | ZURAITIS MARITA President & CEO | Exercise | 71.5K @ $42.95 | $3.07M |
| 2026-06-24 | ZURAITIS MARITA President & CEO | Tax | 65.5K @ $50.75 | $3.32M |
| 2026-06-02 | ZURAITIS MARITA President & CEO | Sell | 7.50K @ $46.25 | $347K |
| 2026-05-20 | Samuel Aaliyah A Director | Award | 2.78K @ $46.77 | $130K |
| 2026-05-20 | Fetter Victor Director | Award | 2.78K @ $46.77 | $130K |
| 2026-05-20 | Fetter Victor Director | Award | 1.18K @ $46.77 | $55.0K |
| 2026-05-20 | Sarsynski Elaine A Director | Award | 2.78K @ $46.77 | $130K |
| 2026-05-20 | Reece Henry Wade Director | Award | 2.78K @ $46.77 | $130K |
| 2026-05-20 | McClure Beverley J. Director | Award | 2.78K @ $46.77 | $130K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 sell · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.